Erratum: Waste in the US Health Care System: Estimated Costs and Potential for Savings (JAMA (2019) 322:15 (1501-1509) DOI: 10.1001/jama.2019.13978);Waste in the US Health Care System: Estimated Costs and Potential for Savings

JAMA - Journal of the American Medical Association

Volumn 322, Issue 15, 2019, Pages 1501-1509

  Shrank, William H ^a   Rogstad, Teresa L ^a   Parekh, Natasha ^b  

^a HUMANA INC   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRAUD; GOVERNMENT; GREY LITERATURE; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; REVIEW; UNITED STATES; AMBULATORY CARE; COST CONTROL; DRUG COST; ECONOMICS; HEALTH CARE DELIVERY; HEALTH SERVICE; LABORATORY TECHNIQUE; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; TREATMENT FAILURE; UNNECESSARY PROCEDURE;

CLINICAL LABORATORY TECHNIQUES; COST SAVINGS; DELIVERY OF HEALTH CARE; DRUG COSTS; FRAUD; HEALTH EXPENDITURES; HUMANS; MEDICAL OVERUSE; OFFICE VISITS; TREATMENT FAILURE; UNITED STATES; UNNECESSARY PROCEDURES;

EID: 85073005712     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2020.0228     Document Type: Erratum

References (69)

1. Papanicolas I, Woskie LR, Jha AK. Health care spending in the United States and other high-income countries. JAMA. 2018; 319 (10): 1024-1039. doi: 10.1001/jama.2018.1150 29536101
2. The Healthcare Imperative. Lowering Costs and Improving Outcomes: Workshop Series Summary. Washington, DC: Institute of Medicine of the National Academies; 2010.
3. Berwick DM, Hackbarth AD. Eliminating waste in US health care. JAMA. 2012; 307 (14): 1513-1516. doi: 10.1001/jama.2012.362 22419800
4. Dusetzina SB, Huskamp HA, Keating NL. Specialty drug pricing and out-of-pocket spending on orally administered anticancer drugs in Medicare Part D, 2010 to 2019. JAMA. 2019; 321 (20): 2025-2027. doi: 10.1001/jama.2019.4492 31135837
5. Califf RM, Slavitt A. Lowering cost and increasing access to drugs without jeopardizing innovation. JAMA. 2019; 321 (16): 1571-1573. doi: 10.1001/jama.2019.3846 31012911
6. Kaltenboeck A, Bach PB. Value-based pricing for drugs: theme and variations. JAMA. 2018; 319 (21): 2165-2166. doi: 10.1001/jama.2018.4871 29710320
7. Burci GL, Gostin LO. Privatized pharmaceutical innovation vs access to essential medicines: a global framework for equitable sharing of benefits. JAMA. 2017; 317 (5): 473-474. doi: 10.1001/jama.2016.17994 28170485
8. Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016; 316 (8): 858-871. doi: 10.1001/jama.2016.11237 27552619
9. Woolhandler S, Himmelstein DU. Single-payer reform: the only way to fulfill the president's pledge of more coverage, better benefits, and lower costs. Ann Intern Med. 2017; 166 (8): 587-588. doi: 10.7326/M17-0302 28241256
10. Casalino LP, Gans D, Weber R, US physician practices spend more than 15.4 billion annually to report quality measures. Health Aff (Millwood). 2016; 35 (3): 401-406. doi: 10.1377/hlthaff.2015.1258 26953292
11. Tseng P, Kaplan RS, Richman BD, Shah MA, Schulman KA. Administrative costs associated with physician billing and insurance-related activities at an academic health care system. JAMA. 2018; 319 (7): 691-697. doi: 10.1001/jama.2017.19148 29466590
12. Colla CH, Morden NE, Sequist TD, Schpero WL, Rosenthal MB. Choosing wisely: prevalence and correlates of low-value health care services in the United States. J Gen Intern Med. 2015; 30 (2): 221-228. doi: 10.1007/s11606-014-3070-z 25373832
13. Schwartz AL, Chernew ME, Landon BE, McWilliams JM. Changes in low-value services in year 1 of the Medicare pioneer accountable care organization program. JAMA Intern Med. 2015; 175 (11): 1815-1825. doi: 10.1001/jamainternmed.2015.4525 26390323
14. Schwartz AL, Landon BE, Elshaug AG, Chernew ME, McWilliams JM. Measuring low-value care in Medicare. JAMA Intern Med. 2014; 174 (7): 1067-1076. doi: 10.1001/jamainternmed.2014.1541 24819824
15. Low-value care reduction toolkits, 2019. VBIDHEALTH webpage. http://www.vbidhealth.com/toolkits. Accessed July 10, 2019.
16. PubMed Tutorial. Similar articles. US National Library of Medicine webpage. https://www.nlm.nih.gov/bsd/disted/pubmedtutorial/020-190.html. Updated July 26, 2018. Accessed June 9, 2019.
17. CPI-all urban consumers, 2019. Bureau of Labor Statistics webpage. https://data.bls.gov/cgi-bin/surveymost?cu. Accessed July 10, 2019.
18. Agency for Healthcare Research and Quality. National scorecard on rates of hospital-acquired conditions 2010 to 2015: interim data from national efforts to make health care safer. AHRQ webpage. https://www.ahrq.gov/professionals/quality-patient-safety/pfp/2015-interim.html. Updated December 2016. Accessed June 22, 2019.
19. NQF-Endorsed Measures for Care Coordination. Phase 3, 2014. Washington, DC: National Quality Forum. http://www.qualityforum.org/Publications/2014/12/NQF-Endorsed-Measures-for-Care-Coordination--Phase-3.asp. December 2, 2014. Accessed June 22, 2019.
20. MAP families of measures: safety, care coordination, cardiovascular conditions, diabetes. Washington, DC: National Quality Forum. http://www.qualityforum.org/Publications/2012/10/MAP-Families-of-Measures.aspx. October 2012. Accessed June 27, 2019.
21. Patient safety measures complications-phase 2. Washington, DC: National Quality Forum. http://www.qualityforum.org/Publications/2013/02/Patient-Safety-Measures-Complications---Phase-2.aspx. Accessed February 15, 2013. June 27, 2019.
22. Patient safety 2015 final technical report. Washington, DC: National Quality Forum. http://www.qualityforum.org/Publications/2016/02/Patient-Safety-2015-Final-Report.aspx. February 12, 2016. Accessed June 22, 2019.; 2016.
23. Vaccines are cost saving. Vaccinate Your Family website. https://www.vaccinateyourfamily.org/why-vaccinate/vaccine-benefits/costs-of-disease-outbreaks. Updated April 8, 2019. Accessed June 27, 2019.
24. The truth about the prevention fund [news release]. Washington, DC: Trust for America's Health; June 6, 2013. https://www.tfah.org/article/tfah-releases-the-truth-about-the-prevention-fund. Accessed June 27, 2019.
25. Tice JA, Chapman R, Shore K, Diabetes prevention programs: effectiveness and value: draft evidence report. Boston, MA: Institute for Clinical and Economic Review. https://icer-review.org/wp-content/uploads/2016/05/CTAF-DPP-Draft-Evidence-Report-050916-1.pdf. May 9, 2016. Accessed June 27, 2019.
26. Ahn S, Basu R, Smith ML, The impact of chronic disease self-management programs: healthcare savings through a community-based intervention. BMC Public Health. 2013; 13: 1141. doi: 10.1186/1471-2458-13-1141 24314032
27. Clough JD, Patel K, Riley GF, Rajkumar R, Conway PH, Bach PB. Wide variation in payments for Medicare beneficiary oncology services suggests room for practice-level improvement. Health Aff (Millwood). 2015; 34 (4): 601-608. doi: 10.1377/hlthaff.2014.0964 25847642
28. Clough JD, Patel K, Shrank WH. Variation in specialty outpatient care patterns in the Medicare population. J Gen Intern Med. 2016; 31 (11): 1278-1286. doi: 10.1007/s11606-016-3745-8 27259290
29. Lallemand NC. Reducing waste in health care. HealthAffairs policy brief. https://www.healthaffairs.org/do/10.1377/hpb20121213.959735/full. Posted December, 2012. Accessed June 29, 2019.
30. Financing and payment strategies to support high-quality care for people with serious illness. Proceedings of a Workshop. Washington, DC: National Academy of Sciences. http://www.nationalacademies.org/hmd/Reports/2018/financing-and-payment-strategies-to-support-high-quality-care-for-people-with-serious-illness-proceedings.aspx. May 16, 2018. Accessed June 29, 2019.
31. Hines AL, Barrett ML, Jiang J, Steiner CA. Conditions with the largest number of adult hospital readmissions by payer, 2011. Healthcare Cost and Utilization Project (HCUP); statistical brief 172. https://www.hcup-us.ahrq.gov/reports/statbriefs/sb172-Conditions-Readmissions-Payer.pdf. April 2014. Accessed June 29, 2019.
32. Langer-Gould AM, Anderson WE, Armstrong MJ, The American Academy of Neurology's top five choosing wisely recommendations. Neurology. 2013; 81 (11): 1004-1011. doi: 10.1212/WNL.0b013e31828aab14 23430685
33. Mannocci A, De Carli G, Di Bari V, How much do needlestick injuries cost? a systematic review of the economic evaluations of needlestick and sharps injuries among healthcare personnel. Infect Control Hosp Epidemiol. 2016; 37 (6): 635-646. doi: 10.1017/ice.2016.48 27022671
34. Mulcahy AW, Hlavka JP, Case SR. Biosimilar cost savings in the united states: initial experience and future potential. Rand Health Q. 2018; 7 (4): 3. 30083415
35. Making medicines affordable: a national imperative. Washington, DC: National Academies of Sciences. https://www.nap.edu/catalog/24946/making-medicines-affordable-a-national-imperative. Published 2018. Accessed June 30, 2019.
36. Reid RO, Rabideau B, Sood N. Low-value health care services in a commercially insured population. JAMA Intern Med. 2016; 176 (10): 1567-1571. doi: 10.1001/jamainternmed.2016.5031 27571327
37. Carter MW, Zhu M, Xiang J, Porell FW. Investigating the long-term consequences of adverse medical events among older adults. Inj Prev. 2014; 20 (6): 408-415. doi: 10.1136/injuryprev-2013-041043 24871958
38. French EB, McCauley J, Aragon M, End-of-life medical spending in last twelve months of life is lower than previously reported. Health Aff (Millwood). 2017; 36 (7): 1211-1217. doi: 10.1377/hlthaff.2017.0174 28679807
39. Haber S, Beil H, Amico P, Evaluation of the Maryland all-payer model. RTI International. Waltham, MA: RTI International. https://downloads.cms.gov/files/cmmi/md-all-payer-thirdannrpt.pdf. Published March 2018. Accessed June 30, 2019.
40. Cooper Z, Craig SV, Gaynor M, Reenen JV. The price ain't right? hospital prices and health spending on the privately insured. Cambridge, MA: National Bureau of Economic Research. https://www.nber.org/papers/w21815. Revised May 2018. Accessed June 30, 2019.
41. Whaley C, Schneider Chafen J, Pinkard S, Association between availability of health service prices and payments for these services. JAMA. 2014; 312 (16): 1670-1676. doi: 10.1001/jama.2014.13373 25335149
42. Medicare fraud: progress made, but more action needed to address Medicare fraud, waste, and abuse. https://www.gao.gov/assets/670/662845.pdf. April 30, 2014. Accessed June 30, 2019.
43. Goldman TR. Eliminating fraud and abuse. HealthAffairs blog. https://www.healthaffairs.org/do/10.1377/hpb20120731.55945/full. Posted July 31, 2012. Accessed June 30, 2019.
44. McGee J, Sandridge L, Treadway C, Vance K, Coustasse A. Strategies for fighting Medicare fraud. Health Care Manag (Frederick). 2018; 37 (2): 147-154. 29697574
45. Gee E, Spiro T. Excess administrative costs burden the US health care system. Center for American Progress webpage. https://www.americanprogress.org/issues/healthcare/reports/2019/04/08/468302/excess-administrative-costs-burden-u-s-health-care-system. Published April 8, 2019. Accessed July 17, 2019.
46. Agency for Healthcare Research and Quality. Statewide, all-payer financial incentives significantly reduce hospital-acquired conditions in Maryland hospitals. AHRQ Innovations Exchange. https://innovations.ahrq.gov/profiles/statewide-all-payer-financial-incentives-significantly-reduce-hospital-acquired-conditions. Updated August 13, 2014. Accessed June 27, 2019.
47. Alper J, Grossman C. Integrating Research and Practice. Health System Leaders Working Toward High-Value Care: Workshop Summary. Washington, DC: National Academies of Sciences; 2015.
48. Agency for Healthcare Research and Quality. Hospital gain-sharing program offers incentives to physicians based on their efficiency, producing significant cost savings without decline in quality. AHRQ Health Care Innovations Exchange. https://innovations.ahrq.gov/profiles/hospital-gain-sharing-program-offers-incentives-physicians-based-their-efficiency-producing. Updated August 13, 2014. Accessed June 27, 2019.
49. Liu JL, Lai D, Ringel JS, Vaiana ME, Wasserman J. Small ideas for saving big health care dollars. Rand Health Q. 2014; 4 (1): 4. 28083318
50. Melek SP, Norris DT, Paulus J. Economic impact of integrated medical-bahavioral healthcare: implications for psychiatry. https://www.integration.samhsa.gov/about-us/Milliman-Report-Economic-Impact-Integrated-Implications-Psychiatry.pdf. April 2014. Accessed July 10, 2019.
51. Dummit L, Smathers K, Bright OJ, CMS comprehensive care for joint replacement model: performance year 1 evaluation report. https://innovation.cms.gov/files/reports/cjr-firstannrpt.pdf. August 2018. Accessed June 27, 2019.
52. Liao JM, Emanuel EJ, Whittington GL, Physician practice variation under orthopedic bundled payment. Am J Manag Care. 2018; 24 (6): 287-293. 29939503
53. Centers for Medicare and Medicaid Innovation. Project evaluation activity in support of partnership for patients: interim evaluation report, final. https://downloads.cms.gov/files/cmmi/pfp-interimevalrpt.pdf. Revised December 29, 2015. Accessed June 27, 2019.
54. Agency for Healthcare Research and Quality. On-the-scene video consultations with emergency physicians reduce unnecessary ambuland transports and emergency department visits, connect people to medical homes. AHRQ Health Care Innovations Exchange. https://innovations.ahrq.gov/profiles/scene-video-consultations-emergency-physicians-reduce-unnecessary-ambulance-transports-and. Updated November 5, 2015. Accessed June 29, 2019.
55. Agency for Healthcare Research and Quality. Accountable care organization featuring shared global risk stimulates development of initiatives to improve care, reduces inpatient use and costs. AHRQ Health Care Innovations Exchange. https://innovations.ahrq.gov/profiles/accountable-care-organization-featuring-shared-global-risk-stimulates-development. Updated June 4, 2014. Accessed June 29, 2019.
56. Agency for Healthcare Research and Quality. State-financed, primary care-led, accountable care collaborative provides comprehensive, coordinated care to medicaid beneficiaries, reducing admissions, use of imaging services, and costs. AHRQ Health Care Innovations Exchange. https://innovations.ahrq.gov/profiles/state-financed-primary-care-led-accountable-care-collaborative-provides-comprehensive. Updated July 2, 2014. Accessed June 29, 2019.
57. Agency for Healthcare Research and Quality. Statewide health information exchange provides daily alerts about emergency department and inpatient visits, helping health plans and accountable care organizations reduce utilization and costs. AHRQ Health Care Innovations Exchange. https://innovations.ahrq.gov/profiles/statewide-health-information-exchange-provides-daily-alerts-about-emergency-department-and. Updated March 12, 2014. Accessed June 29, 2019.
58. Duiz D, McNealy K, Corey K, Simmerman J. Final evaluation report: evaluation of the community-based care transitions program. Bethesda, MD: Econometrica Inc. Mathematica Policy Research. November 2017. https://downloads.cms.gov/files/cmmi/cctp-final-eval-rpt.pdf. November 2017. Accessed June 29, 2019.
59. Schurrer J, O'Malley A, Wilson C, McCall N, Jain N. Evaluation of the Diffusion and Impact of the Chronic Care Management (CCM) Services: Final Report. Washington, DC: Mathematica Policy Research. https://www.mathematica-mpr.com/our-publications-and-findings/publications/evaluation-of-the-diffusion-and-impact-of-the-chronic-care-management-ccm-services-final-report. November 2, 2017. Accessed September 9, 2019.
60. Medicare Payment Advisory Committee. Medicare and the Health Care Delivery System: Report to the Congress. http://medpac.gov/docs/default-source/reports/Jun11-EntireReport.pdf. June 2011. Accessed June 30, 2019.
61. Evaluation of the shared decision making (SDM) and medication management (MM) health care innovation awardees Third Annual Report Addendum. Burlingame, CA: Acumen LLD. https://downloads.cms.gov/files/cmmi/hcia-shareddecisionmaking-medmgt-thirdannualaddendum.pdf. June 2017. Accessed June 30, 2019.
62. Powers BW, Makar M, Jain SH, Cutler DM, Obermeyer Z. Cost savings associated with expanded hospice use in Medicare. J Palliat Med. 2015; 18 (5): 400-401. doi: 10.1089/jpm.2015.0014 25806563
63. PWC Health Research Institute. CMS considers foreign drug prices to hold down Medicare Part B spending. https://www.pwc.com/us/en/health-industries/health-research-institute/assets/pdf/CMS-considers-foreign-drug-prices-Medicare-Part-B-PwC-HRI-2019.pdf. Published January 2019. Accessed June 30, 2019.
64. Lieberman DA, Polinski JM, Choudhry NK, Avorn J, Fischer MA. Medicaid prescription limits: policy trends and comparative impact on utilization. BMC Health Serv Res. 2016; 16: 15. doi: 10.1186/s12913-016-1258-0 26772962
65. Health Care Fraud and Abuse Control Program: annual report for fiscal year 2017. Dept of Health and Human Services and Dept of Justice. https://oig.hhs.gov/publications/docs/hcfac/FY2017-hcfac.pdf. Published April 2018. Accessed June 30, 2019.
66. Annual report to Congress on the Medicare and Medicaid integrity programs for fiscal years 2013 and 2014. Baltimore, MD: Centers for Medicare & Medicaid Services. https://www.cms.gov/About-CMS/Components/CPI/Downloads/2016-07-15-FY-2013-2014-MandM-PI-RTC-FINAL.PDF. Accessed June 30, 2019.
67. Carter EA, Morin PE, Lind KD. Costs and trends in utilization of low-value services among older adults with commercial insurance or Medicare Advantage. Med Care. 2017; 55 (11): 931-939. doi: 10.1097/MLR.0000000000000809 28930892
68. Sisko AM, Keehan SP, Poisal JA, National health expenditure projections, 2018-27: economic and demographic trends drive spending and enrollment growth. Health Aff (Millwood). 2019; 38 (3): 491-501. doi: 10.1377/hlthaff.2018.05499 30785832
69. Lotvin AM, Shrank WH, Singh SC, Falit BP, Brennan TA. Specialty medications: traditional and novel tools can address rising spending on these costly drugs. Health Aff (Millwood). 2014; 33 (10): 1736-1744. doi: 10.1377/hlthaff.2014.0511 25288417